GlaxoSmithkline Pharmaceuticals Ltd.

About

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap50,149 Cr

P/E47.60

Div Yield1.93 %

Book Value₹134.00

52w High₹3,121.00

52w Low₹2,088.00

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	938.00	995.00	1,041.00	980.00	805.00	974.00	949.00	1,011.00	815.00	930.00	805.00	957.00	762.00
Expenses	643.00	644.00	670.00	644.00	554.00	641.00	658.00	689.00	584.00	673.00	587.00	668.00	618.00
Operating Profit	296.00	351.00	371.00	336.00	251.00	333.00	292.00	322.00	231.00	257.00	218.00	289.00	144.00
OPM %	31.00	35.00	36.00	34.00	31.00	34.00	31.00	32.00	28.00	28.00	27.00	30.00	19.00
Other Income	44.00	36.00	50.00	36.00	44.00	41.00	35.00	39.00	36.00	32.00	-135.00	28.00	54.00
Depreciation	16.00	13.00	20.00	17.00	16.00	15.00	19.00	17.00	16.00	18.00	17.00	18.00	16.00
Interest	1.00	1.00	1.00	1.00	0.00	1.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00
Profit before tax	322.00	373.00	400.00	354.00	279.00	359.00	308.00	344.00	249.00	271.00	65.00	299.00	181.00
Tax %	26.00	26.00	26.00	27.00	27.00	27.00	25.00	27.00	27.00	28.00	30.00	27.00	27.00
Net Profit	237.00	278.00	296.00	257.00	205.00	263.00	230.00	252.00	182.00	194.00	46.00	218.00	132.00
EPS in Rs	14.00	16.40	17.45	15.20	12.10	15.52	13.57	14.91	10.76	11.48	2.70	12.84	7.81

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	3,822.00	3,749.00	3,454.00	3,252.00	3,278.00	2,926.00	3,224.00	3,128.00	2,871.00	2,908.00	2,838.00	3,305.00
Expenses	2,512.00	2,570.00	2,545.00	2,447.00	2,516.00	2,327.00	2,567.00	2,527.00	2,363.00	2,489.00	2,360.00	2,672.00
Operating Profit	1,309.00	1,179.00	909.00	804.00	762.00	598.00	657.00	601.00	508.00	420.00	478.00	633.00
OPM %	34.00	31.00	26.00	25.00	23.00	20.00	20.00	19.00	18.00	14.00	17.00	19.00
Other Income	166.00	149.00	-21.00	103.00	1,401.00	9.00	-262.00	131.00	70.00	119.00	125.00	149.00
Interest	3.00	1.00	2.00	2.00	2.00	4.00	6.00	1.00	0.00	0.00	0.00	0.00
Depreciation	66.00	67.00	70.00	66.00	68.00	79.00	83.00	49.00	38.00	27.00	25.00	25.00
Profit before tax	1,406.00	1,260.00	816.00	839.00	2,093.00	525.00	306.00	683.00	540.00	511.00	578.00	756.00
Tax %	26.00	26.00	28.00	27.00	19.00	32.00	70.00	35.00	35.00	34.00	35.00	37.00
Net Profit	1,036.00	928.00	590.00	611.00	1,695.00	358.00	93.00	445.00	351.00	337.00	376.00	476.00
EPS in Rs	61.15	54.75	34.83	36.05	100.04	21.14	5.50	26.29	20.70	19.88	22.20	28.12
Dividend Payout %	93.00	99.00	92.00	89.00	90.00	142.00	727.00	76.00	85.00	75.00	113.00	111.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	169.00	169.00	169.00	169.00	169.00	169.00	169.00	169.00	85.00	85.00	85.00	85.00
Reserves	2,098.00	1,782.00	1,608.00	1,572.00	2,494.00	1,309.00	1,651.00	1,970.00	1,973.00	1,922.00	2,099.00	1,744.00
Borrowings	33.00	10.00	19.00	16.00	20.00	35.00	0.00	1.00	1.00	2.00	2.00	3.00
Other Liabilities	2,023.00	2,147.00	1,760.00	1,570.00	1,950.00	1,602.00	1,315.00	1,771.00	1,889.00	995.00	869.00	1,384.00
Total Liabilities	4,324.00	4,108.00	3,557.00	3,327.00	4,633.00	3,115.00	3,136.00	3,911.00	3,947.00	3,004.00	3,055.00	3,216.00
Fixed Assets	281.00	284.00	321.00	330.00	331.00	387.00	758.00	432.00	325.00	258.00	204.00	123.00
CWIP	33.00	14.00	14.00	20.00	30.00	13.00	120.00	1,003.00	923.00	605.00	268.00	115.00
Investments	1,392.00	1,118.00	813.00	518.00	366.00	0.00	0.00	0.00	0.00	0.00	6.00	0.00
Other Assets	2,618.00	2,692.00	2,408.00	2,458.00	3,907.00	2,715.00	2,257.00	2,477.00	2,700.00	2,140.00	2,577.00	2,977.00
Total Assets	4,324.00	4,108.00	3,557.00	3,327.00	4,633.00	3,115.00	3,136.00	3,911.00	3,947.00	3,004.00	3,055.00	3,216.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	903.00	1,290.00	582.00	484.00	811.00	578.00	490.00	409.00	473.00	234.00	139.00	338.00
Cash from Investing Activity	397.00	-46.00	9.00	808.00	-406.00	418.00	-57.00	-153.00	-104.00	301.00	499.00	180.00
Cash from Financing Activity	-737.00	-769.00	-562.00	-1,543.00	-524.00	-696.00	-428.00	-358.00	-307.00	-511.00	-638.00	-497.00
Net Cash Flow	563.00	475.00	29.00	-251.00	-119.00	300.00	6.00	-102.00	62.00	24.00	0.00	21.00
Free Cash Flow	870.00	1,273.00	573.00	451.00	2,371.00	536.00	336.00	166.00	639.00	-24.00	-69.00	175.00
CFO/OP %	93.00	116.00	92.00	93.00	122.00	121.00	103.00	101.00	133.00	94.00	72.00	93.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	26.00	28.00	23.00	22.00	23.00	27.00	11.00	14.00	19.00	21.00	16.00	11.00
Inventory Days	124.00	126.00	144.00	131.00	144.00	159.00	135.00	131.00	147.00	111.00	156.00	91.00
Days Payable	154.00	186.00	171.00	122.00	156.00	135.00	100.00	109.00	149.00	73.00	97.00	74.00
Cash Conversion Cycle	-4.00	-31.00	-4.00	31.00	11.00	50.00	46.00	36.00	17.00	60.00	75.00	27.00
Working Capital Days	-91.00	-99.00	-64.00	-57.00	-94.00	-39.00	-38.00	-72.00	-90.00	7.00	26.00	-48.00
ROCE %	61.00	63.00	51.00	36.00	37.00	38.00	33.00	31.00	26.00	22.00	29.00	42.00

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00	75.00
FIIs	4.79	4.62	4.63	4.79	4.89	4.52	4.50	4.36	4.02	3.48	2.93	2.50
DIIs	7.81	7.68	7.70	7.75	7.71	7.79	7.30	7.34	7.51	7.90	8.64	10.01
Public	12.42	12.69	12.67	12.45	12.41	12.69	13.21	13.30	13.48	13.62	13.42	12.48
No. of Shareholders	126,087	121,763	122,460	122,904	123,629	121,885	119,625	119,228	118,515	118,994	114,663	115,268

Corporate Actions

29 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	29 May 2026	29 May 2026	—	57.00
Dividend	30 May 2025	30 May 2025	—	42.00
Dividend	07 Nov 2024	07 Nov 2024	—	12.00
Dividend	31 May 2024	31 May 2024	—	32.00
Dividend	30 Jun 2023	30 Jun 2023	—	32.00
Dividend	07 Jul 2022	08 Jul 2022	—	60.00	NSE/BSE dividend mismatch: BSE/NSE=30.0; BSE/NSE=60.0
Dividend	07 Jul 2022	08 Jul 2022	—	30.00	NSE/BSE dividend mismatch: BSE/NSE=30.0; BSE/NSE=60.0
Dividend	19 Jul 2021	20 Jul 2021	—	30.00
Dividend	17 Jul 2020	20 Jul 2020	—	20.00
Dividend	11 Jul 2019	—	—	20.00
Bonus	11 Sep 2018	13 Sep 2018	1:1	—
Dividend	13 Jul 2018	—	—	35.00
Dividend	14 Jul 2017	—	—	30.00
Dividend	15 Jul 2016	—	—	50.00
Dividend	23 Jul 2015	—	—	62.50
Dividend	03 Apr 2014	—	—	50.00
Dividend	04 Apr 2013	—	—	50.00
Dividend	29 Mar 2012	—	—	45.00
Dividend	14 Mar 2011	—	—	40.00
Dividend	10 Mar 2010	—	—	30.00
Other	10 Mar 2010	—	—	—	Dividend-Rs.30/- Pr Share
Dividend	18 Mar 2009	—	—	40.00
Other	18 Mar 2009	—	—	—	Div Fin-Rs.22 + Spl-Rs.18
Dividend	02 Apr 2008	—	—	36.00
Other	02 Apr 2008	—	—	—	Div Fin-Rs18+Spl-18 Pr Sh
Other	14 Mar 2007	—	—	—	Div Fin-170% + Spl-140% Purpose Revised
Other	24 Mar 2006	—	—	—	Fin Div-Rs14+Spl Div-Rs14
Dividend	27 Mar 2002	—	—	5.50
Dividend	02 May 2001	—	—	5.00

Announcements

5 filings

Announcement under Regulation 30 (LODR)-Newspaper Publication 2 Sep
02 Sep 2026
Corrigendum To The Notice Of Postal Ballot Dated August 3, 2026 1 Sep
01 Sep 2026
Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd
26 Aug 2026 26 Aug - Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 26, 2026, with reference to Movement in Volume.
Volume Movement Letter
26 Aug 2026 26 Aug - Company says recent share volume spike is market-driven, with no undisclosed material information.
Disclosure Under Regulation 30
19 Aug 2026 19 Aug - GSK received Rs 4.99 crore income tax refund for AY 2025-26.